Targeting bone metastases in metastatic castration-resistant prostate cancer
Skeletal involvement in metastatic castrate-resistant prostate cancer (mCRPC) is common and results in significant morbidity and mortality. The interaction of prostate cancer with the bone microenvironment contributes to progression of cancer in the bone leading to skeletal-related events (SREs). St...
Saved in:
| Main Author: | El-Amm, Joelle (author) |
|---|---|
| Other Authors: | Aragon-Ching, Jeanny B. (author) |
| Format: | article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/10725/6244 http://dx.doi.org/ 10.4137/CMO.S30751 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807885/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bone-targeted therapies in metastatic castration-resistant prostate cancer
by: El-Amm, Joelle
Published: (2013) -
Metastatic castration-resistant prostate cancer
by: El-Amm, Joelle
Published: (2013) -
The changing landscape in the treatment of metastatic castration-resistant prostate cancer
by: El Amm, Joelle
Published: (2012) -
Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer
by: El-Amm, Joelle
Published: (2017) -
Enzalutamide for patients with metastatic castration-resistant prostate cancer
by: Ramadan, Wijdan H.
Published: (2015)